CN102526591B - Special effect Chinese herbal medicine composition for treating leukemia - Google Patents
Special effect Chinese herbal medicine composition for treating leukemia Download PDFInfo
- Publication number
- CN102526591B CN102526591B CN201210014358.0A CN201210014358A CN102526591B CN 102526591 B CN102526591 B CN 102526591B CN 201210014358 A CN201210014358 A CN 201210014358A CN 102526591 B CN102526591 B CN 102526591B
- Authority
- CN
- China
- Prior art keywords
- herbal medicine
- chinese
- patient
- medicine composition
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 7
- 230000000694 effects Effects 0.000 title abstract description 22
- 208000032839 leukemia Diseases 0.000 title abstract description 17
- 241000411851 herbal medicine Species 0.000 title abstract 3
- 241000959626 Calvatia Species 0.000 claims description 12
- 241001489978 Eupolyphaga Species 0.000 claims description 12
- 241001243091 Gryllotalpa Species 0.000 claims description 12
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 12
- 241000180649 Panax notoginseng Species 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 7
- 230000002045 lasting effect Effects 0.000 claims description 2
- 208000032843 Hemorrhage Diseases 0.000 abstract description 4
- 208000007502 anemia Diseases 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 3
- 230000002607 hemopoietic effect Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000000295 complement effect Effects 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 230000001613 neoplastic effect Effects 0.000 abstract description 2
- 241000219068 Actinidia Species 0.000 abstract 1
- 241000331983 Arisaema consanguineum Species 0.000 abstract 1
- 241000596154 Belamcanda Species 0.000 abstract 1
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 241001489980 Eupolyphaga sinensis Species 0.000 abstract 1
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 abstract 1
- 241000133638 Holothuria scabra Species 0.000 abstract 1
- 241000133231 Marshallia caespitosa Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 241000529895 Stercorarius Species 0.000 abstract 1
- 241001482963 Thamnophis Species 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 24
- 210000001185 bone marrow Anatomy 0.000 description 10
- 238000002512 chemotherapy Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000736919 Pelodiscus sinensis Species 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000026784 acute myeloblastic leukemia with maturation Diseases 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003443 bladder cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001501 megacaryocyte Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a Chinese herbal medicine composition for treating leukemia, belonging to the technical field of Chinese medicines. The composition consists of two prescriptions which complement with each other and consolidate effects mutually. Major components of the special effect Chinese herbal medicine composition include garter snake, panax pseudo-ginseng, parslane herb, dried alum, crude arisaema consanguineum schott, holothuria scabra jaeger, depositum urinae hominis, puffball, interior eardamom, Chinese actinidia root, blackberry lily, white mustard seed, mole cricket and eupolyphaga sinensis walker. The Chinese medicinal composition has good effects on clinical common anemia, fever, infection, hemorrhage and liver, speech and lymphadenectasis; and according to a second prescription, neoplastic hyperplasia of leukemia cells in marrow or other hemopoietic tissues can be eliminated, and the physique of a patient can be enhanced simultaneously.
Description
Technical field
The present invention relates to a kind of leukemic herbal composite for the treatment of, be specifically related to the leukemic herbal composite of a kind of effective treatment, belong to technical field of Chinese medicines.
Background technology
Leukemia people are commonly called as leukemia, are a kind of very strong malignant diseases that seriously jeopardizes human health of damage hematopoietic stem cell that destroys.Along with the development of Protocols in Molecular Biology, leukemic etiology Yi Cong colony medical science, cytobiology enter molecular biological research.Although it is relevant with leukemia generation that many factors are considered to, the definite cause of disease of human leukemia is not bright so far.Aspect leukemic pathogenic factor, still think and infection at present, radiation factor, chemical factor, inherited genetic factors is relevant, clinical manifestation be anemia, hemorrhage, infect and each organ infiltrates symptom.The method of leukemia treating has a lot, substantially can be divided into Western medicine and two kinds for the treatment of meanss of Chinese medicine, and Western medicine is the therapeutic modality that current patient often selects, current Therapeutic Method mainly contains radiotherapy, chemotherapy, the doctor trained in Western medicine methods such as bone marrow transplant, though radiotherapy or chemotherapy can be killed part cancerous cell, make patient symptom temporarily take a turn for the better or alleviate, but when it kills and wounds cancerous cell, injured normal immunocyte leukocyte, damaged human righteousness, side effect is large, to patient, brings insufferable misery, and some critical patient is forced to therapy discontinued.Western medicine not only can not fundamentally be cured patient disease, and too large its curative effect that also usually surpasses of toxic and side effects, seriously deviate from mutually with mankind's environmental protection thought day by day, result makes many chronic diseases in therapeutic process, primary disease is not cured, and because but the toxic and side effects of medicine causes more disease, even the seriousness of these diseases surpasses primary disease.What is more, the toxic and side effects of some Western medicine more than ten years or even the throwback outbreak of hiding.In fact, Chinese medicine is many to leukemia treating benefit: Chinese medicine can induced apoptosis in leukemia cell lines, promotes apoptosis of leukemia; Promote normal cell to transform.Some Chinese medicine can promote that leukaemia transforms to normal cell, and leukaemia is turned over a new leaf, thereby makes leukemic treatment reach a good curative effect; Antagonism chemotherapy side effect.Because chemotherapy has very large toxic and side effects to patient, and Chinese medicine can resist chemotherapy side effect, promotion is subject to the recovery of alimentary canal mucous membrane cell, conscience kidney and other organ-tissue cell functions of chemotherapy damage, protective hair bladder cell, reduce alopecia, reduce patient's pain; Hemopoietic function protecting.Chinese medicine can also be protected the recovery of normal hematopoiesis function bone marrow, prevents that chemotherapeutics from causing serious bone marrow depression, reduces blood transfusion, alleviate hemorrhage, improper release symptom; Recover immunologic function.Some Chinese medicines can also promote the recovery of normal immunologic function, reduce and infect complication, avoid patient to bring larger pain.
At present, a lot of patients often too pay attention to the leukemic treatment of doctor trained in Western medicine, thereby have ignored Bai disorders of blood therapeutic modality, probably can lose one and originally can recover healthy, even the chance of recovery from illness.
Summary of the invention
The object of this invention is to provide a kind of leukemic herbal composite for the treatment of, this herbal composite can effectively be treated leukemia.
In order to address the above problem, the technical solution adopted in the present invention is:
Treat a leukemic herbal composite, said composition is comprised of two prescriptions, and two sides complement one another, mutually lasting effects:
Side one: Zaocys 10-30g, Radix Notoginseng 20-30g, Herba Portulacae 50-80g, dried Alumen 5-20g, Rhizoma Arisaematis 10-25g, BAISHASHEN 10-30g, calamitas urinae hominis 5-15g, Lasiosphaera Seu Calvatia 10-20g, Fructus Amomi 5-15g, Radix Actinidiae Chinensis 10-30g, Rhizoma Belamcandae 15-50g, Semen Sinapis Albae 30-60g, Gryllotalpa 5-20g, Eupolyphaga Seu Steleophaga 15-25g; With tabletting after medicine-feeding raw material 3 times of concentration extraction, become human oral every day 3 times, each 3 grams, one after each meal, child's consumption cuts down according to the circumstance, general continuous taking medicine after two months, hemogram is normal, and from three month, monthly oral 7 days to consolidate curative effect;
Side two: Zaocys 50-80g, Radix Notoginseng 80-120g, Herba Portulacae 70-150g, dried Alumen 10-25, Rhizoma Arisaematis 30-80g, BAISHASHEN 15-50g, calamitas urinae hominis 15-30g, Lasiosphaera Seu Calvatia 20-40g, Fructus Amomi 15-30g, Radix Actinidiae Chinensis 90-250g, Rhizoma Belamcandae 65-110g, Semen Sinapis Albae 20-45g, Gryllotalpa 15-35g, Eupolyphaga Seu Steleophaga 40-100; Medicine-feeding is according to tabletting after above ratio 5 times of concentration extraction, becomes human oral every day 3 times, and 4g, bfore meals at every turn, child's consumption cuts down according to the circumstance, general continuous taking medicine after two months, and bone marrow smear is alleviated completely, from 3rd month, monthly only take 7 days, with side one together with to consolidate curative effect.
The invention has the beneficial effects as follows:
Anemia, heating, infection, hemorrhage regulating liver-QI spleen, lymphadenectasis that a pair of leukemia in side often has clinically have good effect, and Fang Erke eliminates the neoplastic hyperplasia of leukaemia in bone marrow or other hemopoietic tissue.
Patient takes medicine after two months continuously, and since three month, monthly only need take medicine 7 days (checking that hemogram is normal, after bone marrow smear is alleviated) was to consolidate curative effect 4 months.After four months according under its type of leukemia with the inherent situation of its health, advise respectively patient to join Chinese medicine water proof with Trionyx sinensis Wiegmann, Serpentis, toad etc. and steam in clear soup and monthly within several days, take, after general three to five years, patient is very strong.
Case 1: name: Taurus town, Daye City, Yin Yue fairy maiden age 60Sui Hubei Province is the field people of family recklessly.
Be diagnosed as acute lymphoblastic leukemia on May 19th, 1998.Wuhan University the People's Hospital at that time and People's Hospital, Hubei Province's hemanalysis report.
Bone is worn and is shown: nucleated cell obvious proliferation, former prolymphocyte 90%, grain, red two all suppressed, megalokaryocyte has no.
Because chemical therapy toxic side effect is too large, patient's retinal hemorrhage, diet is not good enough, and household brings and sees a doctor, and patient takes medicine after two months continuously, from three month, monthly takes 7 days again, consolidates curative effect 4 months.It is very fast that sb.'s illness took a favorable turn.
After 7 months, on January 6th, 2009, do hemogram, bone marrow smear inspection.Result is that bone marrow smear is alleviated, hemogram is normal.On January 6th, 1999, hemogram situation is as follows:
Systemic edema, left rib pain, dizzy pupil situation disappear completely, abdominal distention gas, dyspepsia, constipation, sleep all recover finely, and can go on the market and buy vegetables, and in family, cook, sweep the floor.Advise its stewing Serpentis and Chinese medicine every other month, the next day one, within 10 days, take continuously 5 Serpentiss; Also can hold concurrently and eat Trionyx sinensis Wiegmann.Follow up a case by regular visits to 11 years, be with again her to go to check after its sub-a year and a half, bone is worn and is shown and reach alleviation, repeatedly checks hemogram and recovers normal recovery from illness.
Case 2: name: will man age 54Sui Huangshi people from city learns in side.
San the People's Hospital, Huangshi, in JIUYUE, 2003 24 Hubei Province hematology is diagnosed as that " acute myeloblastic leukemia M2 type, without special treatment, goes to Tumour Hospital, Hubei Prov., conventional WBC2.5 * 10 of having a blood test
9hB112g/1PLT38 * 10
9, row bone marrow is through at the type into AML-M2, gives " AA ", and " MA " * 2 are checked bone marrow and are reached the catabasis after scheme chemotherapy.
Toxic and side effects whole body jaundice after twice chemotherapy.Patient finds me upon somebody's introduction afterwards, I examine into marrow consumptive disease (pyretic toxicity in knot, deficiency of both QI and YIN) clothes for patients medication after two months, feeling sick in the time of just, vomiting disappears, the palpitation and short breath after jaundice disappearance, activity is not obvious, spiritual muscle power is obviously strong before.Take medicine again continuously to consolidate curative effect four months, monthly take medicine seven days, measure constant.On April 3rd, 2004, patient's hemogram checking is normal, and bone marrow examination patient extremely fear, and is afraid of that pain be unwilling to conduct a survey.Only has for many years hemogram result.But visit 8 years, patient is fine.From taking medicine, Second Year starts, and I advise patient to take Trionyx sinensis Wiegmann steaming Radix Salviae Miltiorrhizae, Fructus Crataegi, Radix Pseudostellariae, eat every other month 5, and patient can take exercise on foot at a quick pace and practise taijiquan every day now.Houseworks such as playing tennis, buy vegetables, cook.This Spring Festival, patient came to home to pay a New Year call, and patient tells me, and he and the cotemporary person do not have difference, can use up its natural life-span eventually.
The specific embodiment
Below by embodiment, the present invention is described in further details, these embodiment are only used for illustrating the present invention, do not limit the scope of the invention.
Embodiment 1
Side one: Zaocys 10g, Radix Notoginseng 20g, Herba Portulacae 50g, dried Alumen 5g, Rhizoma Arisaematis 10g, BAISHASHEN 10g, calamitas urinae hominis 5g, Lasiosphaera Seu Calvatia 10g, Fructus Amomi 5g, Radix Actinidiae Chinensis 10g, Rhizoma Belamcandae 15g, Semen Sinapis Albae 30g, Gryllotalpa 5g, Eupolyphaga Seu Steleophaga 15g; Side two: Zaocys 50g, Radix Notoginseng 80g, Herba Portulacae 70g, dried Alumen 10g, Rhizoma Arisaematis 30g, BAISHASHEN 15g, calamitas urinae hominis 15g, Lasiosphaera Seu Calvatia 20g, Fructus Amomi 15g, Radix Actinidiae Chinensis 90g, Rhizoma Belamcandae 65g, Semen Sinapis Albae 20g, Gryllotalpa 15g, Eupolyphaga Seu Steleophaga 40g.
Embodiment 2
Side one: Zaocys 30g, Radix Notoginseng 30g, Herba Portulacae 80g, dried Alumen 20g, Rhizoma Arisaematis 25g, BAISHASHEN 30g, in people from 15g, Lasiosphaera Seu Calvatia 20g, Fructus Amomi 15g, Radix Actinidiae Chinensis 30g, Rhizoma Belamcandae 50g, Semen Sinapis Albae 60g, Gryllotalpa 20g, Eupolyphaga Seu Steleophaga 25g;
Side two: Zaocys 80g, Radix Notoginseng 120g, Herba Portulacae 150g, dried Alumen 25g, Rhizoma Arisaematis 80g, BAISHASHEN 50g, calamitas urinae hominis 30g, Lasiosphaera Seu Calvatia 40g, Fructus Amomi 30g, Radix Actinidiae Chinensis 250g, Rhizoma Belamcandae 110g, Semen Sinapis Albae 45g, Gryllotalpa 35g, Eupolyphaga Seu Steleophaga 100g.Embodiment 3
Side one: Zaocys 20g, Radix Notoginseng 25g, Herba Portulacae 65g, dried Alumen 15g, Rhizoma Arisaematis 20g, BAISHASHEN 20g, calamitas urinae hominis 10g, Lasiosphaera Seu Calvatia 15g, Fructus Amomi 10g, Radix Actinidiae Chinensis 20g, Rhizoma Belamcandae 25g, Semen Sinapis Albae 45g, Gryllotalpa 15g, Eupolyphaga Seu Steleophaga 20g;
Side two: Zaocys 65g, Radix Notoginseng 100g, Herba Portulacae 110g, dried Alumen 20g, Rhizoma Arisaematis 55g, BAISHASHEN 30g, calamitas urinae hominis 25g, Lasiosphaera Seu Calvatia 30g, Fructus Amomi 25g, Radix Actinidiae Chinensis 150g, Rhizoma Belamcandae 85g, Semen Sinapis Albae 35g, Gryllotalpa 25g, Eupolyphaga Seu Steleophaga 70g.
Embodiment 4
Side one: Zaocys 15g, Radix Notoginseng 20g, Herba Portulacae 60g, dried Alumen 10g, Rhizoma Arisaematis 15g, BAISHASHEN 20g, in people from 12g, Lasiosphaera Seu Calvatia 15g, Fructus Amomi 10g, Radix Actinidiae Chinensis 20g, Rhizoma Belamcandae 20g, Semen Sinapis Albae 40g, Gryllotalpa 10g, Eupolyphaga Seu Steleophaga 20g;
Side two: Zaocys 60g, Radix Notoginseng 90g, Herba Portulacae 100g, dried Alumen 15g, Rhizoma Arisaematis 45g, BAISHASHEN 40g, calamitas urinae hominis 20g, Lasiosphaera Seu Calvatia 25g, Fructus Amomi 20g, Radix Actinidiae Chinensis 130g, Rhizoma Belamcandae 90g, Semen Sinapis Albae 30g, Gryllotalpa 20g, Eupolyphaga Seu Steleophaga 50g.
Claims (1)
1. the leukemic herbal composite for the treatment of, is characterized in that: said composition is comprised of two prescriptions, complements one another, mutually lasting effects:
Side one: Zaocys 10-30g, Radix Notoginseng 20-30g, Herba Portulacae 50-80g, dried Alumen 5-20g, Rhizoma Arisaematis 10-25g, BAISHASHEN 10-30g, calamitas urinae hominis 5-15g, Lasiosphaera Seu Calvatia 10-20g, Fructus Amomi 5-15g, Radix Actinidiae Chinensis 10-30g, Rhizoma Belamcandae 15-50g, Semen Sinapis Albae 30-60g, Gryllotalpa 5-20g, Eupolyphaga Seu Steleophaga 15-25g;
Side two: Zaocys 50-80g, Radix Notoginseng 80-120g, Herba Portulacae 70-150g, dried Alumen 10-25g, Rhizoma Arisaematis 30-80g, BAISHASHEN 15-50g, calamitas urinae hominis 15-30g, Lasiosphaera Seu Calvatia 20-40g, Fructus Amomi 15-30g, Radix Actinidiae Chinensis 90-250g, Rhizoma Belamcandae 65-110g, Semen Sinapis Albae 20-45g, Gryllotalpa 15-35g, Eupolyphaga Seu Steleophaga 40-100g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210014358.0A CN102526591B (en) | 2012-01-16 | 2012-01-16 | Special effect Chinese herbal medicine composition for treating leukemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210014358.0A CN102526591B (en) | 2012-01-16 | 2012-01-16 | Special effect Chinese herbal medicine composition for treating leukemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526591A CN102526591A (en) | 2012-07-04 |
| CN102526591B true CN102526591B (en) | 2014-03-26 |
Family
ID=46335411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210014358.0A Expired - Fee Related CN102526591B (en) | 2012-01-16 | 2012-01-16 | Special effect Chinese herbal medicine composition for treating leukemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526591B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112451635A (en) * | 2021-01-11 | 2021-03-09 | 河南鹿真堂中医药科技研究院有限公司 | Chinese herbal medicine oral liquid for treating leukemia and preparation method and equipment thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100473388C (en) * | 2004-06-15 | 2009-04-01 | 上海医药科技发展有限公司 | Extraction of effective portion of gryllotalpidae for anti-cancers and preparation thereof |
| CN101195022A (en) * | 2007-12-03 | 2008-06-11 | 门连社 | Chinese medicine prescription for curing tumor |
| CN101199667A (en) * | 2007-12-24 | 2008-06-18 | 李志宏 | Chinese medicine for treating leukemia, aplastic anemia |
| CN101670056B (en) * | 2008-09-10 | 2011-08-03 | 吴昆仑 | Medicament for treating malignant tumor |
-
2012
- 2012-01-16 CN CN201210014358.0A patent/CN102526591B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526591A (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102671054A (en) | Traditional Chinese medicine composition for treating thrombophlebitis | |
| CN103920034B (en) | Chinese medicine composition and the method for making of the side reaction of ameliorate tumor chemotherapy of patients | |
| CN103520659B (en) | Traditional Chinese medicine for treating cancer | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN101559203B (en) | Chinese medicament preparation for treating angina pectoris | |
| CN102716334B (en) | Chinese medicinal composition for dispelling the cold and removing stasis | |
| CN102614424B (en) | Traditional Chinese medicine for treatment of edema | |
| CN107375845A (en) | The topical composition and its application method that dispelling wind and eliminating dampness is clearing and activating the channels and collaterals | |
| CN102526591B (en) | Special effect Chinese herbal medicine composition for treating leukemia | |
| CN101327280B (en) | Chinese medicine for treating paralysis | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN105031532A (en) | Traditional Chinese medicine composition for treating seroperitoneum and preparation thereof | |
| CN104587339A (en) | Traditional Chinese medicine soaking agent for treating chemotherapy-related peripheral nerve toxicity | |
| CN103446575A (en) | Medicine for treating gout | |
| CN103251754A (en) | Traditional Chinese medicine composition for treating bedsore | |
| CN103316175A (en) | Traditional Chinese medicine powder, and preparation method and application thereof | |
| CN106138537A (en) | A kind of Chinese medicine preparation treating overall pain and preparation method thereof | |
| CN106377716A (en) | Traditional Chinese medicine composition for treating dysentery | |
| CN103230547B (en) | Traditional Chinese medicine for treating intractable hiccup | |
| CN104623432A (en) | Traditional Chinese medicine composition for performing elimination treatment on tumor | |
| CN103505670A (en) | Traditional Chinese medicine composition for treating primary bronchus lung cancer | |
| CN101301412B (en) | Capsules for soothing depression and dissipating binds | |
| CN1289123C (en) | Medicine for treating late malignant tumour | |
| CN104435979B (en) | A kind of medicine for treating rheumatic lumbocrural pain pain | |
| CN104258309A (en) | Traditional Chinese medicine composition for treating cancers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20151029 Address after: Panyu Panyu Shatou Street 510000 Guangdong province Guangzhou city Shanxi Road No. 329 building 4 Building 804, 805, 806 and 1 Patentee after: Guangzhou Heheng Bio-pharmaceutical Technology Co., Ltd. Address before: 510000, Guangzhou, Guangdong, Haizhuqu District province Xingang Road, arts street, No. seven, Patentee before: Yin Yongzhou |
|
| DD01 | Delivery of document by public notice |
Addressee: Guangzhou Heheng Bio-pharmaceutical Technology Co., Ltd. Document name: Notification of Passing Examination on Formalities |
|
| DD01 | Delivery of document by public notice |
Addressee: Guangzhou Heheng Bio-pharmaceutical Technology Co., Ltd. Document name: Notice of amendment |
|
| DD01 | Delivery of document by public notice |
Addressee: Guangzhou Heheng Bio-pharmaceutical Technology Co., Ltd. Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Guangzhou Heheng Bio-pharmaceutical Technology Co., Ltd. Document name: Notification to Pay the Fees |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 Termination date: 20190116 |